What is Celldex Therapeutics's common stock?

Celldex Therapeutics (CLDX) reported common stock of $67K in Q1 2026.

How has Celldex Therapeutics's common stock changed year-over-year?

Celldex Therapeutics's common stock increased by 1.5% year-over-year, from $66K to $67K.

What is the long-term trend for Celldex Therapeutics's common stock?

Over 5 years (2020 to 2025), Celldex Therapeutics's common stock has grown at a 10.9% compound annual growth rate (CAGR), from $40K to $67K.

What does common stock mean?

The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Celldex Therapeutics CLDX Common Stock

Common Stock at other companies

Eli LillyLLY

$590M-0.4%

Rogers CorporationROG

$17.8M-3.8%

AmgenAMGN

2.8B0.0%

IncyteINCY

400M0.0%

AbbVieABBV

$18M0.0%

Arcutis Biotherapeutics, Inc.ARQT

300M0.0%

Other financials

Income statement

See full

Revenue$15.0K-97.8%

Operating income-$84.4M-34.6%

Net income-$78.7M-46.3%

EPS (diluted)-$1.18-45.7%

Balance sheet

See full

Cash & equivalents$35.7M+109%

Total debt$1.9M-44.3%

Total equity$456.2M-35.1%

Total assets$511.3M-30.9%

Cash flow

See full

Operating cash flow-$65.6M-20.6%

CapEx$1.6M+518%

Free cash flow-$67.2M-23.0%

Valuation

See full

Market cap$2.59B+75.2%

Enterprise value$2.55B+74.4%

P/S2,989.2×+2,794×

Profitability

See full

Operating margin-35,688.5%-39,114pp

Net margin-32,753.6%-35,519pp

FCF margin-26,125.8%-28,907pp

Returns & leverage

See full

Return on equity-48.9%-498pp

Debt / equity0×0.0×

Current ratio8.9×-12.7×

Where this comes from

Reported directly by Celldex Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Celldex Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celldex Therapeutics's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Celldex Therapeutics's common stock?: Celldex Therapeutics (CLDX) reported common stock of $67K in Q1 2026.
How has Celldex Therapeutics's common stock changed year-over-year?: Celldex Therapeutics's common stock increased by 1.5% year-over-year, from $66K to $67K.
What is the long-term trend for Celldex Therapeutics's common stock?: Over 5 years (2020 to 2025), Celldex Therapeutics's common stock has grown at a 10.9% compound annual growth rate (CAGR), from $40K to $67K.
What does common stock mean?: The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).